Schedule 13G ownership disclosure
REATA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 75615P103
Event date: 2022-08-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,508,638
- Percent of class
- 4.7800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-22-000051
- Form type
- SC 13G
- Filer
- REATA PHARMACEUTICALS INC
- CIK
- CIK 1358762
- Filed
- Sep 09, 2022
- Reporting period
- Aug 31, 2022
- Description
- Schedule 13G beneficial ownership